metastatic cervical carcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)

Phase 2 (1)

Interventional (1)

Akeso (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmajor surgery

I am/have/hadepithelial carcinoma

I am/have/hadcancer treatment

I am/have/hadcervical cancer

I am/have/hadmetastatic cervical carcinoma

I am/have/hadmetastatic cervical cancer

I am/have/hadformalin-fixed paraffin-embedded

I am/have/hadadenosquamous cell carcinoma of the cervix

I am/have/hadpd-l1

I am/have/hadmetastasis

I am/have/hadcarcinoma

I am/have/hadcancer

I am/have/hadadenosquamous carcinoma

I am/have/hadsquamous cell carcinoma

I am/have/hadcervical carcinoma

added new label for I am/have/had

more

I am looking for

I am looking forcorticosteroids

I am looking forattenuated vaccines

I am looking forprednisone

I am looking forbevacizumab

I am looking forimmunosuppressive

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

major surgery

cervical cancer

immunosuppressive

pd-l1

adenosquamous carcinoma

0 views
16 Feb, 2024
20 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.